We speculate that multi-ligand inhibition might therefore advantageously prevent overlapping as well as distinct activities of activin-class ligands, which could be mutually reinforcing in the therapeutic treatment of cardiovascular disease. This evidence concerns the gene INHBE and cardiovascular disorder.